Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.

Chen JL, Appelbaum DE, Kocherginsky M, Cowey CL, Rathmell WK, McDermott DF, Stadler WM. FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer. Cancer Med. 2013 Aug; 2(4):545-52.

View in: PubMed

collapse authors with profiles